1.795USD+0.56%Mkt Cap: 114.36M USDP/E: —Last update: 2026-06-01
Pyxis Oncology, Inc., a clinical stage company, engages in the development of therapeutics to treat solid tumors. Its lead antibody-drug conjugates (ADC) product candidate is PYX-201, an investigational novel ADC consist…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap114.36M USD
Enterprise Value91.28M USD
Revenue (TTM)13.86M USD
Gross Profit11.47M USD
Net Income (TTM)-79.62M USD
Revenue/Share0.2210 USD
Last Price1.795 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees56
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.47
PEG—
EV/EBITDA-1.17
EV/Revenue6.59
P/S8.23
P/B3.64
EPS (TTM)-1.30
EPS (Forward)-1.23
52W Range
0.970018% of range5.550
52W High5.550 USD
52W Low0.9700 USD
Profitability
Gross Margin82.77%
Oper. Margin-600.20%
EBITDA Margin0.00%
Profit Margin-574.55%
ROE-149.08%
ROA-87.00%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-63.50M USD
CapEx (TTM)9.00K USD
FCF Margin—
FCF Yield—
Net Debt-22.76M USD
Net Debt/EBITDA0.29
Balance Sheet
Debt/Equity0.35
Current Ratio2.76
Quick Ratio2.48
Book Value/Sh0.4940 USD
Cash/Share0.6470 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)6.889 USD
Target Range5.000 USD – 9.000 USD
# Analysts9
Ownership
Shares Out.63.36M
Float40.72M
Insiders22.13%
Institutions33.86%
Short Interest
Short Ratio3.0d
Short % Float3.87%
Short % Out.2.86%
Shares Short1.81M
Short (prev mo.)2.27M
Technical
SMA 501.781 (+0.8%)
SMA 2002.258 (-20.5%)
Beta1.43
S&P 52W Chg27.70%
Avg Vol (30d)616.48K
Avg Vol (10d)726.12K
Technical Indicators
RSI (14)44.8
MACD-0.0178
MACD Signal0.0595
MACD Hist.-0.0773
BB Upper2.808 USD
BB Middle2.093 USD
BB Lower1.378 USD
BB Width68.34%
ATR (14)0.2317 USD
Vol Ratio (20d)0.35x